Scorecard › META
META analyst scorecard · Meta Platforms
83 rating actions on META in the last 12 months. Of 46 price targets that resolved, 12 were reached while they stood, 34 were replaced by the same firm first, and 0 fell short at their deadline. Ratings: 90% Buy-type, 10% Hold-type, 0% Sell-type. Consensus target $805, 6% above the last close.
Checked through 2026-10-13 · last close $762.50 (2026-10-13). Rebuilt every morning.
Targets reached while they stood
26.1% 12 of 46
Replaced before the deadline
73.9%
Short at the deadline
0.0%
Ratings vs XLC
—
Buy / Hold / Sell, 12 mo
90 / 10 / 0%
Consensus target
$805 +5.6%
What the Holds say: 4 Hold-type ratings on META in the last 12 months carried a median target +7% from the price on the day; 25% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Rosenblatt | Buy | 2026-10-13 | $886 | 0 | 3 | 3 | — |
| Wells Fargo | Overweight | 2026-10-06 | $1000 | 1 | 5 | 6 | — |
| UBS | Buy | 2026-07-30 | $715 | 1 | 3 | 4 | — |
| Guggenheim | Buy | 2026-07-30 | $700 | 1 | 3 | 4 | — |
| JPMorgan | Overweight | 2026-09-24 | $920 | 0 | 2 | 2 | — |
| Wedbush | Neutral | 2026-09-14 | $650 | 1 | 0 | 1 | — |
| Citigroup | Buy | 2026-09-16 | $800 | — | — | 0 | — |
| Baird | Outperform | 2026-07-30 | $750 | 1 | 0 | 1 | — |
| Goldman Sachs | Buy | 2026-07-30 | $725 | 1 | 0 | 1 | — |
| Susquehanna | Positive | 2026-07-30 | $650 | 1 | 0 | 1 | — |
| DA Davidson | Buy | 2026-07-30 | $700 | 1 | 0 | 1 | — |
| Mizuho | Outperform | 2026-05-05 | $835 | — | — | 0 | — |
| Truist Securities | Buy | 2026-10-13 | $1000 | 1 | 2 | 3 | — |
| Evercore ISI Group | Outperform | 2026-08-25 | $860 | 0 | 2 | 2 | — |
| KeyBanc | Overweight | 2026-10-13 | $900 | 0 | 2 | 2 | — |
| Cantor Fitzgerald | Overweight | 2026-10-12 | $840 | 1 | 2 | 3 | — |
| TD Cowen | Buy | 2026-10-08 | $865 | 1 | 1 | 2 | — |
| Piper Sandler | Overweight | 2026-09-25 | $875 | 0 | 2 | 2 | — |
| RBC Capital | Outperform | 2026-09-24 | $770 | 0 | 2 | 2 | — |
| Bank of America | Buy | 2026-09-22 | $810 | 0 | 1 | 1 | — |
| Barclays | Overweight | 2026-07-30 | $780 | 0 | 1 | 1 | — |
| Citizens | Market Outperform | 2026-09-24 | $885 | 1 | 2 | 3 | — |
| Raymond James | Strong Buy | 2026-09-24 | $860 | 0 | 1 | 1 | — |
| Needham | Hold | 2026-08-27 | — | — | — | 0 | — |
| Pivotal Research | Buy | 2026-10-13 | $930 | — | — | 0 | — |
| Deutsche Bank | Buy | 2026-09-25 | $820 | — | — | 0 | — |
| Canaccord Genuity | Buy | 2026-09-25 | $950 | — | — | 0 | — |
| Tigress Financial | Strong Buy | 2026-09-24 | $995 | — | — | 0 | — |
| StoneX | Hold | 2026-09-22 | — | — | — | 0 | — |
| Jefferies | Buy | 2026-09-22 | $875 | — | — | 0 | — |
| Benchmark | Hold | 2026-08-27 | — | — | — | 0 | — |
| Rothschild & Co | Buy | 2026-07-21 | $1000 | — | — | 0 | — |
| Erste Group | Buy | 2026-07-07 | — | — | — | 0 | — |
| Stifel | Buy | 2026-05-01 | $780 | — | — | 0 | — |
| Bernstein | Outperform | 2026-04-30 | $850 | — | — | 0 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor META carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Pivotal Research | Buy | maintained | $762.50 | $930 | running to 2027-10-13 | +17.7% |
| 2026-10-13 | Truist Securities | Buy | maintained | $762.50 | $1000 | running to 2027-10-13 | +17.7% |
| 2026-10-13 | KeyBanc | Overweight | reiterated | $762.50 | $900 | running to 2027-10-13 | +17.7% |
| 2026-10-13 | Rosenblatt | Buy | maintained | $762.50 | $886 | running to 2027-10-13 | +17.7% |
| 2026-10-12 | Cantor Fitzgerald | Overweight | maintained | $742.96 | $840 | running to 2027-10-12 | +14.7% |
| 2026-10-08 | TD Cowen | Buy | reiterated | $720.89 | $865 | running to 2027-10-08 | +17.5% |
| 2026-10-06 | Wells Fargo | Overweight | maintained | $738.88 | $1000 | running to 2027-10-06 | +19.8% |
| 2026-09-25 | Deutsche Bank | Buy | maintained | $751.66 | $820 | running to 2027-09-25 | +30.5% |
| 2026-09-25 | Canaccord Genuity | Buy | maintained | $751.66 | $950 | running to 2027-09-25 | +30.5% |
| 2026-09-25 | TD Cowen | Buy | maintained | $751.66 | $865 | running to 2027-09-25 | +30.5% |
| 2026-09-25 | Piper Sandler | Overweight | maintained | $751.66 | $875 | running to 2027-09-25 | +30.5% |
| 2026-09-24 | Raymond James | Strong Buy | maintained | $777.59 | $860 | running to 2027-09-24 | +36.4% |
| 2026-09-24 | Tigress Financial | Strong Buy | maintained | $777.59 | $995 | running to 2027-09-24 | +36.4% |
| 2026-09-24 | JPMorgan | Overweight | maintained | $777.59 | $920 | running to 2027-09-24 | +36.4% |
| 2026-09-24 | RBC Capital | Outperform | reiterated | $777.59 | $770 | within 5% of price when set | +36.4% |
| 2026-09-24 | Citizens | Market Outperform | maintained | $777.59 | $885 | running to 2027-09-24 | +36.4% |
| 2026-09-23 | KeyBanc | Overweight | maintained | $744.10 | $900 | running to 2027-09-23 | +33.1% |
| 2026-09-23 | Cantor Fitzgerald | Overweight | maintained | $744.10 | $860 | replaced 2026-10-12, new $840 | +33.1% |
| 2026-09-22 | Bank of America | Buy | reiterated | $736.60 | $810 | running to 2027-09-22 | +34.0% |
| 2026-09-22 | StoneX | Hold | reiterated | $736.60 | — | no target | +34.0% |
| 2026-09-22 | Jefferies | Buy | maintained | $736.60 | $875 | running to 2027-09-22 | +34.0% |
| 2026-09-21 | Wells Fargo | Overweight | maintained | $741.25 | $796 | replaced 2026-10-06, new $1000 | +34.8% |
| 2026-09-16 | Citigroup | Buy | maintained | $673.31 | $800 | running to 2027-09-16 | +18.3% |
| 2026-09-16 | Rosenblatt | Buy | maintained | $673.31 | $886 | running to 2027-09-16 | +18.3% |
| 2026-09-14 | Wedbush | Neutral | maintained | $665.60 | $650 | within 5% of price when set | +12.8% |
| 2026-09-10 | JPMorgan | Neutral → Overweight | upgrade | $644.38 | $820 | replaced 2026-09-24, new $920 | +7.5% |
| 2026-09-01 | Wedbush | Neutral | reiterated | $578.54 | $595 | within 5% of price when set | +3.9% |
| 2026-08-27 | Rosenblatt | Buy | maintained | $571.10 | $886 | running to 2027-08-27 | -3.8% |
| 2026-08-27 | Benchmark | Hold | reiterated | $571.10 | — | no target | -3.8% |
| 2026-08-27 | Truist Securities | Buy | maintained | $571.10 | $763 | reached 2026-09-24 | -3.8% |
| 2026-08-27 | Needham | Hold | reiterated | $571.10 | — | no target | -3.8% |
| 2026-08-25 | Evercore ISI Group | Outperform | maintained | $570.05 | $860 | running to 2027-08-25 | -4.2% |
| 2026-07-30 | UBS | Buy | maintained | $539.03 | $715 | reached 2026-09-21 | -4.3% |
| 2026-07-30 | Baird | Outperform | maintained | $539.03 | $750 | reached 2026-09-24 | -4.3% |
| 2026-07-30 | Goldman Sachs | Buy | maintained | $539.03 | $725 | reached 2026-09-21 | -4.3% |
| 2026-07-30 | Citigroup | Buy | maintained | $539.03 | $800 | running to 2027-07-30 | -4.3% |
| 2026-07-30 | Susquehanna | Positive | maintained | $539.03 | $650 | reached 2026-09-09 | -4.3% |
| 2026-07-30 | Piper Sandler | Overweight | reiterated | $539.03 | $785 | replaced 2026-09-25, new $875 | -4.3% |
| 2026-07-30 | Truist Securities | Buy | maintained | $539.03 | $770 | replaced 2026-08-27, new $763 | -4.3% |
| 2026-07-30 | TD Cowen | Buy | maintained | $539.03 | $750 | reached 2026-09-24 | -4.3% |
| 2026-07-30 | DA Davidson | Buy | maintained | $539.03 | $700 | reached 2026-09-21 | -4.3% |
| 2026-07-30 | Citizens | Market Outperform | maintained | $539.03 | $770 | reached 2026-09-24 | -4.3% |
| 2026-07-30 | Evercore ISI Group | Outperform | maintained | $539.03 | $820 | replaced 2026-08-25, new $860 | -4.3% |
| 2026-07-30 | Wells Fargo | Overweight | maintained | $539.03 | $640 | reached 2026-09-09 | -4.3% |
| 2026-07-30 | Guggenheim | Buy | maintained | $539.03 | $700 | reached 2026-09-21 | -4.3% |
| 2026-07-30 | Wedbush | Neutral | maintained | $539.03 | $595 | reached 2026-08-11 | -4.3% |
| 2026-07-30 | Cantor Fitzgerald | Overweight | maintained | $539.03 | $680 | reached 2026-09-17 | -4.3% |
| 2026-07-30 | Rosenblatt | Buy | maintained | $539.03 | $883 | replaced 2026-08-27, new $886 | -4.3% |
| 2026-07-30 | KeyBanc | Overweight | maintained | $539.03 | $780 | replaced 2026-09-23, new $900 | -4.3% |
| 2026-07-30 | Barclays | Overweight | maintained | $539.03 | $780 | running to 2027-07-30 | -4.3% |
| 2026-07-30 | Bank of America | Buy | maintained | $539.03 | $810 | running to 2027-07-30 | -4.3% |
| 2026-07-28 | Guggenheim | Buy | reiterated | $593.41 | $800 | replaced 2026-07-30, new $700 | +7.8% |
| 2026-07-21 | Raymond James | Strong Buy | maintained | $643.81 | $850 | replaced 2026-09-24, new $860 | +11.5% |
| 2026-07-21 | Wells Fargo | Overweight | maintained | $643.81 | $835 | replaced 2026-07-30, new $640 | +11.5% |
| 2026-07-21 | Rothschild & Co | Buy | maintained | $643.81 | $1000 | running to 2027-07-21 | +11.5% |
| 2026-07-13 | UBS | Buy | maintained | $656.73 | $766 | replaced 2026-07-30, new $715 | +15.8% |
| 2026-07-10 | Citizens | Market Outperform | maintained | $669.21 | $800 | replaced 2026-07-30, new $770 | +17.2% |
| 2026-07-08 | Needham | Hold | reiterated | $603.12 | — | no target | +3.0% |
| 2026-07-07 | Erste Group | Hold → Buy | upgrade | $615.58 | — | no target | +3.8% |
| 2026-07-02 | Wells Fargo | Overweight | maintained | $582.90 | $767 | replaced 2026-07-21, new $835 | -2.5% |
| 2026-06-01 | RBC Capital | Outperform | reiterated | $600.47 | $810 | replaced 2026-09-24, new $770 | -1.4% |
| 2026-05-28 | Rosenblatt | Buy | maintained | $635.29 | $1015 | replaced 2026-07-30, new $883 | -5.4% |
| 2026-05-20 | Wells Fargo | Overweight | maintained | $605.06 | $765 | replaced 2026-07-02, new $767 | -9.8% |
| 2026-05-05 | Mizuho | Outperform | maintained | $604.96 | $835 | running to 2027-05-05 | +5.3% |
| 2026-05-01 | Stifel | Buy | maintained | $608.75 | $780 | running to 2027-05-01 | +5.1% |
| 2026-04-30 | JPMorgan | Overweight → Neutral | downgrade | $611.91 | $725 | replaced 2026-09-10, new $820 | +7.0% |
| 2026-04-30 | UBS | Buy | maintained | $611.91 | $865 | replaced 2026-07-13, new $766 | +7.0% |
| 2026-04-30 | TD Cowen | Buy | maintained | $611.91 | $800 | replaced 2026-07-30, new $750 | +7.0% |
| 2026-04-30 | Bernstein | Outperform | maintained | $611.91 | $850 | running to 2027-04-30 | +7.0% |
| 2026-04-30 | RBC Capital | Outperform | reiterated | $611.91 | $810 | replaced 2026-09-24, new $770 | +7.0% |
| 2026-04-30 | Piper Sandler | Overweight | reiterated | $611.91 | $800 | replaced 2026-07-30, new $785 | +7.0% |
| 2026-04-30 | Guggenheim | Buy | maintained | $611.91 | $800 | replaced 2026-07-30, new $700 | +7.0% |
| 2026-04-30 | Barclays | Overweight | maintained | $611.91 | $830 | replaced 2026-07-30, new $780 | +7.0% |
| 2026-04-30 | Evercore ISI Group | Outperform | maintained | $611.91 | $930 | replaced 2026-07-30, new $820 | +7.0% |
| 2026-04-30 | Wells Fargo | Overweight | maintained | $611.91 | $770 | replaced 2026-05-20, new $765 | +7.0% |
| 2026-04-30 | Cantor Fitzgerald | Overweight | maintained | $611.91 | $750 | replaced 2026-07-30, new $680 | +7.0% |
| 2026-04-30 | Truist Securities | Buy | maintained | $611.91 | $840 | replaced 2026-07-30, new $770 | +7.0% |
| 2026-04-30 | KeyBanc | Overweight | reiterated | $611.91 | $760 | replaced 2026-07-30, new $780 | +7.0% |
| 2026-04-30 | Rosenblatt | Buy | maintained | $611.91 | $1015 | replaced 2026-07-30, new $883 | +7.0% |
| 2026-04-23 | Guggenheim | Buy | reiterated | $659.15 | $850 | replaced 2026-04-30, new $800 | +11.2% |
| 2026-04-21 | UBS | Buy | maintained | $668.84 | $908 | replaced 2026-04-30, new $865 | +12.7% |
| 2026-04-21 | Citizens | Market Outperform | reiterated | $668.84 | $900 | replaced 2026-07-10, new $800 | +12.7% |
| 2026-04-20 | Bank of America | Buy | maintained | $670.91 | $820 | replaced 2026-07-30, new $810 | +13.0% |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the 7 AM brief
The AM take, today's docket and the Street's calls — one email, weekdays, before the open.